Bob Herman is a business of health care reporter at STAT. He covers hospitals, health insurance, and various aspects of the health care industry, focusing on the financial dynamics within the system. Bob's work has been featured in Axios, Yahoo News, and other notable outlets, highlighting his expertise in health care administration and patient care.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Bob Herman's coverage is heavily focused on the healthcare and pharmaceutical industry in the United States. He tends to cover legal, regulatory, and government announcements related to major players in this sector such as UnitedHealth Group, Humana, and Cigna.
Given his focus on legal policy regulation and citing data, Bob would likely be receptive to pitches from experts who can provide insights into healthcare regulations, antitrust issues within the industry, or analysis of relevant data impacting these companies. Additionally, he may be interested in commentary from professionals with direct knowledge of the operations or policies of major health insurers or providers.
As Bob's geographic focus is national (United States), it would benefit communicators targeting him to tailor their outreach by referencing specific U.S.-based developments within the healthcare and pharmaceutical sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Bob Herman
Some vaccines may no longer be free if ACIP recommendations change The decision by Health and Human Services Secretary Robert F.
This is the online version of STAT's weekly email newsletter Health Care Inc. Sign up here Hello, everyone! Do you have an outstanding medical bill?
By: Bob Herman
Enrollees in Centene's Affordable Care Act plans are a lot sicker than expected
This is the online version of STAT's weekly email newsletter Health Care Inc. Sign up here Hope you had a restful holiday weekend.
By: Bob Herman
The decision marks another loss for the Medicare Advantage industry, which has aggressively sued the federal government in an attempt to overturn reduced quality ratings and retain billions of dollars in taxpayer-funded bonuses.
This is the online version of STAT's weekly email newsletter Health Care Inc. Sign up here
By: Bob Herman, Tara Bannow
The decision is a sign that Medicare, under RJK Jr., is more willing to neuter the AMA's powerful physician panel
By: Tara Bannow, Bob Herman
The decision is a sign that Medicare, under RFK Jr., is more willing to neuter the AMA's powerful physician panel
By: Bob Herman
Hospitals also may face drug cost surveys that could cut payments in the future, again
A federal judge on Friday tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare Advantage plans.
(833) 317-6278 
